CoChat

Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial

Open access
Steare, Thomas, O’Hanlon, Puffin, Eskinazi, Michelle, Osborn, David, Lloyd-Evans, Brynmor, Jones, Rebecca, Rostill, Helen, Amani, Sarah, Johnson, Sonia · 2020 · BMJ Open
Cited by 42

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Objectives: To test the feasibility and acceptability of a randomised controlled trial (RCT) to evaluate a Smartphone-based self-management tool in Early Intervention in Psychosis (EIP) services. Design: A two-arm unblinded feasibility RCT. Setting: Six NHS EIP services in England. Participants: Adults using EIP services who own an Android Smartphone. Participants were recruited until the recruitment target was met (n=40). Interventions: Participants were randomised with a 1:1 allocation to one of two conditions: (1) treatment as usual from EIP services (TAU) or (2) TAU plus access to My Journey 3 on their own Smartphone. My Journey 3 features a range of self-management components including access to digital recovery and relapse prevention plans, medication tracking and symptom monitoring. My Journey 3 use was at the users’ discretion and was supported by EIP service clinicians. Participants had access for a median of 38.1 weeks. Primary and secondary outcome measures: Feasibility outcomes included recruitment, follow-up rates and intervention engagement. Participant data on mental health outcomes were collected from clinical records and from research assessments at baseline, 4 months and 12 months. Results: 83% and 75% of participants were retained in the trial at the 4-month and 12-month assessments. All treatment group participants had access to My Journey 3 during the trial, but technical difficulties caused delays in ensuring timely access to the intervention. The median number of My Journey 3 uses was 16.5 (IQR 8.5 to 23) and median total minutes spent using My Journey 3 was 26.8 (IQR 18.3 to 57.3). No serious adverse events were reported. Conclusions: Recruitment and retention were feasible. Within a trial context, My Journey 3 could be successfully delivered to adults using EIP services, but with relatively low usage rates. Further evaluation of the intervention in a larger trial may be warranted, but should include attention to implementation. Trial registration: ISRCTN10004994 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2019-034927

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 42

Metadata

Authors
Steare, T., O’Hanlon, P., Eskinazi, M., Osborn, D., Lloyd-Evans, B., Jones, R., Rostill, H., Amani, S., & Johnson, S.
Venue
BMJ Open
Publisher
BMJ
Published
2020-08
Volume
10
Issue
8
Pages
e034927
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3081175962
Cited by
42
References
20
FWCI
3.46
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial. https://app.cochat.ai/papers/10.1136/bmjopen-2019-034927
The paper
Steare, T., O’Hanlon, P., Eskinazi, M., Osborn, D., Lloyd-Evans, B., Jones, R., Rostill, H., Amani, S., & Johnson, S. (2020). Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2019-034927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.